Document 2706 DOCN M94A2706 TI Field comparison of line-immunoassays with western blot. DT 9412 AU Maskill W; Tamashiro H; Belsey E; M'Boup S; Wasi C; Liomba G; Gershy-Damet G; Fairfield University Melbourne. SO Int Conf AIDS. 1994 Aug 7-12;10(1):243 (abstract no. PB0401). Unique Identifier : AIDSLINE ICA10/94369869 AB OBJECTIVE: To determine under field conditions the accuracy of line-immunoassays (LIA's) for confirming seropositivity for HIV-1 and HIV-2 as compared to the Western Blot (WB). METHODS: Sera from four countries which were according to WHO WB interpretation criteria positive for HIV-1 (n = 650), HIV-2 (n = 35), both HIV-1 and HIV-2 (n = 63), negative (n = 571) or indeterminate (n = 47) were tested by two LIA's (Inno-Lia and Pepti-Lav). Results of the LIA's were interpreted according to the criteria provided by the test manufacturers. RESULTS: The Inno-Lia and Pepti-Lav tests showed a 98.3% and 98.2% agreement respectively with the WB for HIV-1 positive sera. Both LIA's showed 100% agreement with the WB for HIV-2 positive sera. Both assays showed approximately only a 60% agreement with the WB for sera positive for both HIV-1 and HIV-2 with the remaining sera being positive only for HIV-1. The LIA's found the majority of WB indeterminate sera to be negative, however both tests showed poor specificity due to WB negative sera showing indeterminate reactions. DISCUSSION AND CONCLUSION: Although the Inno-Lia and Pepti-Lav tests show a high level of agreement of WB positive sera, find the majority of WB indeterminate samples non-reactive, and produce a lower number of dually reactive sera, both assays produce a significant number of indeterminate reactions with WB negative sera. The occurrence of these indeterminate reactions may limit the ability of these tests to completely replace the WB. DE AIDS Serodiagnosis/*METHODS *Blotting, Western Comparative Study Human HIV Antibodies/BLOOD HIV Seropositivity/*DIAGNOSIS/IMMUNOLOGY HIV-1/*IMMUNOLOGY HIV-2/*IMMUNOLOGY *Immunoassay Predictive Value of Tests MEETING ABSTRACT SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).